Alexandra Balcom – Insider Trading Activity | DataHeimdall

Alexandra Balcom

Chief Financial Officer at Nuvalent, Inc.

CIK: 1862147

19

Total trades

1

Buys

14

Sells

Jun 2, 2026

Last trade

Date	Stock	Type	Shares	Value	Src
Jun 2, 2026	CBIOCRESCENT BIOPHARMA, INC.	Buy	11,050	–
Jun 1, 2026	NUVLNuvalent, Inc.	Option	11,430	$79K
Jun 1, 2026	NUVLNuvalent, Inc.	Sell	960	$91K
Jun 1, 2026	NUVLNuvalent, Inc.	Sell	2,170	$208K
Jun 1, 2026	NUVLNuvalent, Inc.	Sell	900	$88K
Jun 1, 2026	NUVLNuvalent, Inc.	Sell	1,200	$118K
Jun 1, 2026	NUVLNuvalent, Inc.	Sell	3,133	$313K
Jun 1, 2026	NUVLNuvalent, Inc.	Sell	2,588	$260K
Jun 1, 2026	NUVLNuvalent, Inc.	Sell	279	$28K
Jun 1, 2026	NUVLNuvalent, Inc.	Sell	200	$21K
May 1, 2026	NUVLNuvalent, Inc.	Sell	124	$12K
May 1, 2026	NUVLNuvalent, Inc.	Option	7,159	$8K
May 1, 2026	NUVLNuvalent, Inc.	Option	4,271	$29K
May 1, 2026	NUVLNuvalent, Inc.	Sell	3,872	$381K
May 1, 2026	NUVLNuvalent, Inc.	Sell	7,434	$738K
Apr 1, 2026	NUVLNuvalent, Inc.	Sell	5,417	$570K
Apr 1, 2026	NUVLNuvalent, Inc.	Sell	2,469	$262K
Apr 1, 2026	NUVLNuvalent, Inc.	Option	11,430	$12K
Apr 1, 2026	NUVLNuvalent, Inc.	Sell	3,544	$370K